Commerzbank Analysts Give Carl Zeiss Meditec (AFX) a €42.00 Price Target

Commerzbank set a €42.00 ($50.00) price objective on Carl Zeiss Meditec (ETR:AFX) in a research note issued to investors on Tuesday. The brokerage currently has a neutral rating on the stock.

Other analysts have also issued research reports about the company. Kepler Capital Markets set a €48.50 ($57.74) target price on Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Tuesday. Deutsche Bank set a €49.00 ($58.33) target price on Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Tuesday, February 13th. DZ Bank reaffirmed a sell rating on shares of Carl Zeiss Meditec in a research note on Wednesday, February 14th. Hauck & Aufhaeuser set a €62.50 ($74.40) target price on Carl Zeiss Meditec and gave the stock a buy rating in a research note on Wednesday, February 14th. Finally, Independent Research set a €54.00 ($64.29) target price on Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Monday, February 12th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the stock. The stock currently has an average rating of Hold and a consensus price target of €54.11 ($64.42).

Shares of AFX opened at €57.25 ($68.15) on Tuesday. Carl Zeiss Meditec has a 1 year low of €37.53 ($44.68) and a 1 year high of €55.25 ($65.77).

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit